Citation Impact
Citing Papers
Nucleolar Structure
1984
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
Results of Laparoscopic Sleeve Gastrectomy (LSG) at 1 Year in Morbidly Obese Korean Patients
2005
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
2003
Gastric Bypass Surgery Improves Metabolic and Hepatic Abnormalities Associated With Nonalcoholic Fatty Liver Disease
2006
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
2004
Liver fibrosis
2005 Standout
Laparoscopic adjustable silicone gastric banding for morbid obesity
2001
Outcome after Laparoscopic Adjustable Gastric Banding – 8 Years Experience
2003
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
2001 Standout
Bariatric Surgery
2004 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
A prospective randomized trial of different laparoscopic gastric banding techniques for morbid obesity
2001
Laparoscopic Gastric Bypass: Development of Technique, Respiratory Function, and Long-Term Outcome
2003
Preoperative prediction of severe postoperative pain
2003
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
2003
Benefits of lifestyle modification in NAFLD
2007
In vitro systems for studying intestinal drug absorption
1995
One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study
2005
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
2008
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
AGA technical review on nonalcoholic fatty liver disease
2002
Global cancer statistics
2011 Standout
Laparoscopic gastric banding for morbid obesity
1999
The metabolic syndrome
2005 Standout
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
2006
Non-alcoholic fatty liver disease
2021 Standout
Hernias: inguinal and incisional
2003 Standout
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
2009
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
2012
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome
2007
Surgery for morbid obesity
2005
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Liver Pathology in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass Surgery
2002
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Persistent postsurgical pain: risk factors and prevention
2006 Standout
A Comparison of Suture Repair with Mesh Repair for Incisional Hernia
2000 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Are there Predictive Factors of Severe Liver Fibrosis in Morbidly Obese Patients with Non-alcoholic Steatohepatitis?
2001
The human uncoupling protein‐1 gene (UCP1): present status and perspectives in obesity research
2000
Association of Cardiorespiratory Fitness, Body Mass Index, and Waist Circumference to Nonalcoholic Fatty Liver Disease
2006
G2 block induced by DNA crosslinking agents and its possible consequences
1988
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Medical and surgical options in the treatment of severe obesity
2002
Nonalcoholic fatty liver disease
2005 Standout
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology
2015
Proposal for a histological scoring and grading system for non‐alcoholic fatty liver disease
2005
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
2010
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Ghrelin: Structure and Function
2005 Standout
Laparoscopic Adjustable Gastric Banding for the Treatment of Morbid (Grade 3) Obesity and its Metabolic Complications: A Three-Year Study
2002
AGA technical review on obesity
2002
Hepatocellular Carcinoma
2011 Standout
Diagnosis of fatty liver disease
2003
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Laparoscopic Adjustable Gastric Banding in 1,791 Consecutive Obese Patients: 12-Year Results
2007
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
2003
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
2005
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Bariatric Surgery and Cardiovascular Risk Factors
2011
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery
2003
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Metabolic factors contributing to herniation A review
1998
Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial
2004
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
1997 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
1993 StandoutNobel
Pharmacological and surgical treatment of obesity.
2004
Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment With the Ppar–γ Ligand Rosiglitazone
2003
Benefit of operative mortality reduction on colorectal cancer survival
2002
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
2000
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Isolation and sequencing of NOP1. A yeast gene encoding a nucleolar protein homologous to a human autoimmune antigen.
1990 StandoutNobel
Effects of adriamycin on surface properties of sarcoma 180 ascites cells
1976
Obesity Pathogenesis: An Endocrine Society Scientific Statement
2017
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Identification and characterization of a yeast nucleolar protein that is similar to a rat liver nucleolar protein.
1988 StandoutNobel
The Anthracycline Antineoplastic Drugs
1981 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Works of C Desaive being referenced
Pulmonary function and pain after gastroplasty performed via laparotomy or laparoscopy in morbidly obese patients
1998
Adult groin hernias: new insight into their biomechanical characteristics
1997
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
1998
Long-Term Results of Laparoscopic Adjustable Gastric Banding for the Treatment of Morbid Obesity
2002
Operative mortality following surgery for colorectal cancer
1989
Use of a preperitoneal prosthesis for strangulated groin hernia
1997
Crypt cell isolation in the small intestine of the mouse.
1977
Cytological and Cytochemical Analysis of Ehrlich Ascites Tumor Cells Treated with Daunomycin
1973
[Bariatric surgery: 10-year results of the Swedish Obese Subjects Study].
2005
Pulmonary Function and Pain After Gastroplasty Performed Via Laparotomy or Laparoscopy in Morbidly Obese Patients
1999
Use of a preperitoneal prosthesis for strangulated groin hernia
1997
Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women.
1995
Biomechanical assessment of the transversalis fascia and rectus abdominis aponeurosis in inguinal herniation-Preliminary results
1997
A.420 Pain after gastroplasty with either laparoscopy or laparotomy in morbidly obese patients
1996
Comparative study of the effects of ethidium bromide and dna-ethidium bromide complex on normal and cancer cells
1974
A critical review of a personal series of 1000 gastroplasties.
1995